| 000 | 01273 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514004046.0 | ||
| 264 | 0 | _c20010830 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1389-4501 | ||
| 024 | 7 |
_a10.2174/1389450003349173 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQawi, I | |
| 245 | 0 | 0 |
_aNew developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. _h[electronic resource] |
| 260 |
_bCurrent drug targets _cNov 2000 |
||
| 300 |
_a285-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphatases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 |
_aApyrase _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDipyridamole _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Membrane Glycoproteins _xdrug effects |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 700 | 1 | _aRobson, S C | |
| 773 | 0 |
_tCurrent drug targets _gvol. 1 _gno. 3 _gp. 285-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1389450003349173 _zAvailable from publisher's website |
| 999 |
_c11392919 _d11392919 |
||